Comparative efficacy of secukinumab against adalimumab and infliximab in patients with moderate-to-severe plaque psoriasis

BACKGROUND: Psoriasis is a common, chronic, immune-mediated inflammatory skin disease with increased epidermal proliferation. The objective of this review was to systematically identify the evidence and perform a network meta-analysis (NMA) to estimate the relative efficacy of secukinumab (SEC) agai...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Ran, Wang, Xiaolun, Shu, Min, Das, Jaydeep, Kalra, Manik, Wang, Zhidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850822/
https://www.ncbi.nlm.nih.gov/pubmed/34882622
http://dx.doi.org/10.1097/CM9.0000000000001817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850822/
https://www.ncbi.nlm.nih.gov/pubmed/34882622
http://dx.doi.org/10.1097/CM9.0000000000001817

Ejemplares similares